Categories: Business

Arasan Announces immediate availability of its Total IP for Embedded USB2 (eUSB2) with Controller and PHY

Arasan Chip Systems, a leading provider of semiconductor IP for mobile and automobile SoCs, today announced the immediate availability of its Embedded USB2 (eUSB2) IP Core.

- Advertisement -

SAN JOSE, July 11, 2025 /PRNewswire/ — Arasan Chip Systems, a leading provider of semiconductor IP for mobile and automobile SoCs, today announced the immediate availability of its Total IP for eUSB with the eUSB v2 Controller and eUSB v2 PHY IP. Arasan’s eUSB2 has been designed to target SoCs operating at 1.2V as the interface operating voltage. Arasan is one of the pioneers in the USB IP business having started with USB 1.0 as the company’s first IP product in 1996.

- Advertisement -

Ubiquitous in PCs, eUSB2 is suitable for mobile phones, tablets, and laptops that uses 1.2V/1.0V as the interface operating voltage. eUSB is pervasive in all electronic segments including automotive, enterprise, medical and industrial applications.

- Advertisement -

eUSB2 can support USB high-speed, full-speed, and low-speed operation, as well as the USB 2.0 L1/L2 link power management requirements. In addition, eUSB2 requires no change to the existing USB 2.0 software programming model. eUSB2 also uses the same two data line configurations, eD+ and eD- as USB2 D+ and D-. Vbus and power delivery are not impacted by eUSB2.  

- Advertisement -

Arasan is the only company to offer the complete suite of USB 2.0 IP products including the USB 2.0 Host, Hub, Device, OTG, DRD, eUSB and PHY. Arasan also offers the HSIC option for chip to chip connections over USB.

- Advertisement -

“With 25 years of USB experience and over 150 USB Semiconductor Licensees, Arasan is the pioneer in providing a Total USB IP Solution.”

- Advertisement -

The silicon proven eUSB Controller IP and PHY IP are available to license immediately on advanced nodes on multiple foundries.

- Advertisement -

About Arasan:

- Advertisement -

Arasan Chip Systems is a leading provider of IP for mobile storage and mobile connectivity interfaces, with over a billion chips shipped with our IP. Our high-quality, silicon-proven Total IP Solutions encompass digital IP, Analog Mixed Signal PHY IP, Verification IP, HDK, and Software. With a strong focus on mobile SoCs, we have been at the forefront of the Mobile evolution since the mid-90s, supporting various mobile devices, including smartphones, automobiles, drones, and IoT devices, with our standards-based IP.

- Advertisement -

 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2724563/eUSB2_device_Infographic.jpg

- Advertisement -

Photo – https://mma.prnewswire.com/media/2724564/eUSB2_host_Infographic.jpg

- Advertisement -

Logo – https://mma.prnewswire.com/media/2724571/5400446/Arasan_Chip_Systems_Inc_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/arasan-announces-immediate-availability-of-its-total-ip-for-embedded-usb2-eusb2-with-controller-and-phy-302501790.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

5 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago